Market-Moving News for July 2nd
$RCM
$RDZN
$VS
Other Consumer Services
Consumer Discretionary
Specialty Insurers
Finance
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 8/8/2024 | Overweight → Equal-Weight | Morgan Stanley | ||
| 8/1/2024 | Overweight → Equal-Weight | Stephens | ||
| 8/1/2024 | Outperform → Market Perform | Leerink Partners | ||
| 8/1/2024 | Buy → Hold | Jefferies | ||
| 5/23/2024 | $10.00 | Buy | Maxim Group | |
| 4/10/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | ||
| 3/20/2024 | $16.00 | Neutral → Buy | Citigroup | |
| 2/26/2024 | $14.00 | Outperform | Leerink Partners |
8-K - Versus Systems Inc. (0001701963) (Filer)
424B3 - Versus Systems Inc. (0001701963) (Filer)
POSASR - R1 RCM Inc. /DE (0001910851) (Filer)
8 analysts have shared their evaluations of R1 RCM (NASDAQ:RCM) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 5 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 4 1 0 0 2M Ago 0 1 0 0 0 3M Ago 1 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for R1 RCM, presenting an average target of $17.38, a high estimate of $20.00, and a low estimate of $15.00. Observing a 0.75% increase, t
MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as
MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte
MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.
4 - Roadzen Inc. (0001868640) (Issuer)
4 - Roadzen Inc. (0001868640) (Issuer)
4 - Roadzen Inc. (0001868640) (Issuer)
SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)
SC 13G/A - Versus Systems Inc. (0001701963) (Subject)
SC 13G/A - Roadzen Inc. (0001868640) (Subject)
4 - Roadzen Inc. (0001868640) (Issuer)
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple
VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Versus Systems Inc. (NASDAQ:VS) (the "Company") announces the appointment of Luis Goldner as Chief Executive Officer, effective immediately. Mr. Goldner succeeds Curtis Wolfe, who served as interim CEO and provided invaluable guidance during the transitional period. Mr. Goldner is a member of the Board of Directors of Versus Systems. Mr. Goldner also serves as a member of the Board of Directors of ASPIS Cyber Technologies, Inc., an affiliate of the largest shareholder of Versus Systems. Mr. Goldner brings extensive experience to Versus Systems, having previously served as Chief Executive Officer of Intralot do Brazil, a public
LOS ANGELES, July 22, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ:VS), a pioneering technology company in interactive entertainment and audience engagement solutions, is pleased to announce the appointment of a new interim Chief Financial Officer. Effective immediately, Geoff Deller has been appointed as the new interim Chief Financial Officer of Versus Systems. Geoff Deller brings with him years of experience in finance and investment banking, as well as broad experience within technology companies, including social media, entertainment and SMS messaging. In addition, Geoff has held various executive and advisory positions, at privately owned companies in multiple industry sec
MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w
NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple
Revenue Growth: Achieved second-quarter FY25 revenue of $11.9 million, a 33% increase from the first quarter's revenue of $8.9 million.Improved Path to Profitability: Reported a net loss of $21.8 million, primarily impacted by non-cash, non-recurring, and extraordinary items, resulting in an Adjusted EBITDA¹ loss of $2.1 million, an improvement from the previous quarter's Adjusted EBITDA loss of $2.8 million, reflecting a 25% sequential reduction powered by adoption of AI in reducing operating costs internally.Client Expansion: Added 5 new enterprise clients and over 150 agents and fleets, expanding our services to 108 enterprise clients across insurance and automotive sectors, and 3,550 age
Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight
Stephens downgraded R1 RCM from Overweight to Equal-Weight
Leerink Partners downgraded R1 RCM from Outperform to Market Perform
